Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the CITICS Global Consumer and Healthcare Forum 2026 in Beijing on July 8. (IMAGE)
Caption
He will deliver a keynote speech titled "From Technical Breakthrough to Clinical Validation: The Second Half of AI Drug Discovery."
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content